baber/WOPTO huggingface dataset:
Patent NZ-240936-A (NZ)
Title: Alkoxy-substituted 1-phenyl-isoquinoline derivative and pharmaceutical compositions
Inventor: NAEF RETO
IPC: A61P11/08
Filed: 1991-12-11
Abstract: 6,7-Di(C1-4alkoxy)-1-[3,5-di(C1-4alkoxy)phenyl]-3,4-dihydro-3-hydroxy- methyl-isoquinolines , their physiologically-hydrolysable and -acceptable esters and acid addition salts thereof are novel. The said compounds and esters and pharmaceutically acceptable acid addition salts thereof are useful as pharmaceuticals, e.g. in the treatment of asthma.
Patent NZ-241976-A (NZ)
Title: Use of (hemi)cellulase enzymes for reducing pitch trouble in mechanical
Inventor: JOKINEN OLLI
IPC: D21C9/08
Filed: 1992-03-16
Abstract: The invention relates to a method for reducing the pitch trouble of mechanical pulp and/or papermaking pulp containing mechanical pulp by treating the pulp or white water with a cellulase/hemicellulase enzyme preparation.
Patent NZ-242786-A (NZ)
Title: Hand held apparatus for washing cow's teats; adjustable handle
Inventor: FARINA FELICE
IPC: A01K13/00
Filed: 1992-05-18
Abstract: An apparatus (1) for automatically washing teats of generic dairy animals, specifically dairy cattle, comprises a box-type body (2) provided with an opening (3) for introducing a teat thereinto, and a handgrip (5) jutting out from the box-type body (2) to which it is connected by a means (6) of the swivel type. This handgrip makes the apparatus easier to handle by an operator during a teat washing operation. <IMAGE>
Patent NZ-279509-A (NZ)
Title: Use of 2,4-bisubstituted phenols as 5-lipoxigenase inhibitors
Inventor: BONAL DE FALGAS JOAQUIN
IPC: C07C39/27
Filed: 1995-02-06
Abstract: Products having formula (I) wherein R<2> is (C1-C4)-alkyl, (C1-C4)-acyl, CF3, Cl, Br or I; R<3> is H, (C1-C4)-alkyl, (C1-C4)-acyl, (C1-C4)-alcoxyl, CF3, F, Cl, Br, phenyl, OH, SH, NH2 or amino mono- or bisubstituted by (C1-C3)-alkyl; R<4> is (C1-C4)-alkyl, (C1-C4)-acyl, CF3, F, Cl, Br, I, carboxilo, (C1-C4)-alcoxycarbonyl, cyano, nitro or phenyl; and R<6> is H, (C1-C4)-alkyl, (C1-C4)acyl, CF3, Cl, Br or I, said products presenting, together with a low toxicity, a 5-lipoxigenase inhibiting activity much higher than that of benaprofene or ketoconazol. These characteristics make the disclosed derivates extremely useful for the preparation of drugs against leukotrien-mediated diseases, such as rheumatoid arthritis, ulcerative colitis, asthma, psoriasis and herpes. <CHEM>
Patent NZ-286589-A (NZ)
Title: Continuous process for preparing melamine by pyrolysis of urea under high pressure, the liquid melamine being quenched at high pressure and the byproduct gases being used to preheat the urea
Inventor: BEST DAVID
IPC: C07D251/62
Filed: 1996-05-15
Abstract: A high-pressure, non-catalytic, process for producing melamine from urea wherein the melamine is recovered directly as a dry powder without washing or recrystallization is described. In the process, liquid melamine is fed to a cooling unit where it is quenched with liquid medium, preferably liquid ammonia. Increasing the pressure within the cooling unit to a pressure in excess of 41.4 bar (600 psi) and preferably to 82.7 to 96.5 bar (1200 to 1400 psi) provides melamine having a purity in excess of 99%.
Patent NZ-299619-A (NZ)
Title: Fluid dispenser with a microelectronic dispensation calculator
Inventor: JEWETT WARREN R
IPC: A61M15/00
Filed: 1996-10-22
Abstract: The disclosure is of a device (30) for indicating the number of fluid dispensations remaining in a container (16) for holding and dispensing metered quantities of the fluid. The device (30) is a hermetically-sealed unit which is assembled with the dispenser portion or component of the container and includes microprocessor means (36) for maintaining an inventory of the doses or dispensations remaining of a predetermined number of dispensations. Indicator means (48) signals when the predetermined number of dispensations reaches a level before empty. <IMAGE>   <IMAGE>
Patent NZ-309713-A (NZ)
Title: Oligosaccharides of S pneumoniae serotype 8 and their use in a vaccine
Inventor: MALCOLM ANDREW J
IPC: A61P31/04
Filed: 1996-06-06
Abstract: The application provides immunogenic oligosaccharide compositions and methods of making and using them.  In particular, the compositions comprise oligosaccharides covalently coupled to carrier protein, wherein the resultant conjugate has been shown to contain specific immunogenic epitopes and elicits a protectively immunogenic response. This application also provides compositions comprising an oligosaccharide of S. pneumoniae serotype 8 useful for stimulating an immune response to an antigen, methods of providing protective immunization against a bacterial pathogen using these compositions, methods of augmenting an immunogenic response to an antigen by administering these S. pneumoniae serotype 8 oligosaccharide compositions along with the antigen, and methods of making the immunostimulatory compositions described above.
Patent NZ-331750-A (NZ)
Title: Anchor comprises a base, a shank and stabilizing means
Inventor: REX WILLIAM FRANCIS
IPC: B63B21/32
Filed: 1998-09-07
Abstract: n anchor 1 includes a base member 2 of triangular shape when viewed in plan, with a vertex of triangular shaped base member 2 constituting a leading end of the anchor, which is intended to assisting anchorage of the anchor within a given holding.  Base member 2 is formed from two opposed wing members 3, 4 each triangularly shaped when viewed in plan.  Wing members 3, 4 are joined along a line constituting a centre line 7 for anchor and are disposed at angle to one another such that when viewed in end elevation.  Base member 2 is v-shaped and each wing member includes at the leading or free end thereof, a down-turned portion 6 which constitutes part of the leading end of base member 2 assisting in digging in of anchor in the holding.  A shank member 20 is fixedly attached to base member 2 and is adapted to receive and releasably retain at least one anchor cable.  Stabilizing means 30, 31 is adapted to be attached to base member 2 and serves to ensure that anchor 1 readily assumes its operating configuration and/or is restored to the operating configuration even after having been disturbed therefrom.
Patent NZ-332154-A (NZ)
Title: Process for the production of a magnesium salt of a substituted sulphinyl benzimidazole
Inventor: HOGBERG JAN-AKE
IPC: C07D401/12
Filed: 1997-04-22
Abstract: A process for the preparation of a magnesium salt of formula (I). The process is carried out by mixing the substituted heterocycle with a weak and a magnesium source. The base and the magnesium source are selected to result in residues that are easy to remove during the reaction.
Patent NZ-332500-A (NZ)
Title: Manufacturing brushes comprising immersing bristle ends, which have been passed through the holes of a template, in a liquid, curable material in the bristle carrier
Inventor: WEIHRAUCH GEORG
IPC: A46D3/04
Filed: 1997-04-17
Abstract: A method of manufacturing brushes, e.g. paint brushes, comprises introducing each plastic bristle 4 into one hole of a hole template 7, whose hole diameter is slightly larger than that of a single bristle 4 and whose hole pattern corresponds to the positioning of the bristles within the bristle facing of a bristle carrier (brush ferrule 2), such that the fastening-side ends 14 of the bristles project roughly to the same extent at the opposite side of the template.  The bristles are subsequently fixed against axial and radial displacement in the template.  The fastening-side ends 4 of the bristles are immersed in a bed of liquid, curable material 3 in the bristle carrier such that the material 3 flows round the bristle ends.  The bed of material 3 is subsequently cured.
Patent NZ-333521-A (NZ)
Title: Preparation of secondary fatty ether compounds from their hydroxy fatty acid equivalents
Inventor: ISBELL TERRY A
IPC: C07C67/29
Filed: 1997-05-29
Abstract: The fatty ether compounds possess low viscosity and low temperature melting point properties and may be used as viscosity modifiers in cosmetics and vegetable oil based biodegradable hydraulic fluids and dielectric fluids. The fatty ethers are of above formula (I) wherein R is selected from C7-C17 aliphatic hydrocarbons saturated or unsaturated, linear or branched, and optionally substituted, with one or more hydroxy groups; R1 is selected from the group comprising ethyl, isopropyl, n-butyl, 2-ethylhexyl, decyl, stearyl and oleyl; and x is an integer from 2 to 4. The fatty ester ether compounds are produced by reaction of the hydroxy fatty acid or lactone with an alcohol in the presence of an acid catalyst. The fatty ether esters are recovered, or hydrolyzed to fatty ether acids, or transesterified with a different alcohol in the presence of an acid catalyst to alternate ester variants.
Patent NZ-335038-A (NZ)
Title: A scaled down raster image processor that can be tailored to accomodate image generation in a particular printing range
Inventor: CYMAN THEODORE F
IPC: G06K15/10
Filed: 1997-09-02
Abstract: A reduced cost, scaled down raster image processor (RIP) provides fast real time imaging without the cost and complexity of prior designs. The scaled down RIP can be tailored to accommodate image generation in a particular printing range to efficiently run print bars at a reduced equipment cost. The scaled down RIP utilized a personality module in conjunction with a scaled down controller to provide limited print information to a print engine. The personality module tailors the system for a particular print engine, such as a Moore TM Independent Cartridge Array (MICA) ink jet printer. The personality module is responsible for requesting and reading raster data to build up the staging RAM. A pair of EEPROMs may be used to control each bar read according to the position and distance from the other. Pixel data is then sent to the service station along with the print bar address. The personality module outputs the sequence of pixel data to the service station for imaging, interfaces the display and keyboard information, and transfers the various offsets to a control ASIC for rehandling the pixel data at the staging RAM. The scaled down raster image processor comprised of: (a) A first control circuit which receives a job description file and in response to the job description file, prepares a display lists and transfers fonts for storage in a font image memory; (b) A scaled down control circuit that operates in accordance with the display list and the stored fonts to generate pixel data representing a digital representation of an image; (c) A bit image memory associated with the scale down control circuit, wherein the bit image memory stores the digital image representation generated by the scaled down controller; and (d) A personality module for a print engine, wherein the personality module requests and reads raster data to the selected print engine to operate the print engine and thereby produce an image.
Patent NZ-336421-A (NZ)
Title: Heteromorphic polymer compositions comprising backbone polymer of ethylene/alpha olefin interpolymer and branch from backbone
Inventor: JOHNSTON ROBERT T
IPC: C09D151/00
Filed: 1998-01-06
Abstract: A heteromorphic polymer composition comprises: (a) a homogeneous linear or substantially linear ethylene/a-olefin interpolymer backbone and (b) a branch appending from the backbone and is derived from a branch polymer which is an ethylene homopolymer or ethylene/a-olefin interpolymer having a density which is at least 0.004 g/cm3 greater than that of the backbone polymer and having a higher crystallinity than that of the backbone polymer. A heteromorphic polymer composition comprises a reacted product of: (a) from 40 to 5 weight percent of a branch-forming polymer, which branch comprises an ethylene homopolymer or ethylene/a-olefin interpolymer and (b) from 60 to 95 weight percent of a backbone-forming material which is ethylene and one or more comonomers or which is a homogeneous linear or substantially linear ethylene/a-olefin interpolymer; and wherein the crystallinity the resultant branch is at least 5 percent greater than the crystallinity of the backbone forming material and wherein the heteromorphic polymer composition has an upper service temperature which is at least 100C greater than a non-reacted blend of the polymer of the branch-forming polymer and the backbone forming material. A hot melt adhesive formulation comprising the above defined heteromorphic polymer composition is also disclosed.
Patent NZ-500386-A (NZ)
Title: Ergoline derivatives and their use as somatostatin receptor antagonists
Inventor: STUTZ PETER
IPC: A61P25/28
Filed: 1998-05-27
Abstract: The compound of formula I in free base or acid addition salt form where: R1 is hydrogen, (C1-4)alkyl or a group of formula (a) where n is 1 to 4 and R7 is fluorine, chlorine, hydroxy, (C1-4)alkyl or (C1-4)alkoxy. R2 is hydrogen, chlorine, bromine, iodine, (C1-4)alkyl or (C1-4)alkylthio. R3 is hydrogen or (C1-4)alkyl, R4 is a group of formula (c) or (d) where R8 is fluorine, chlorine, nitro or cyano and R11 is (C1-4)alkyl or (C2-5)alkenyl or a group of formula (e) or (f) where X are independently O or S. R5 and R6 are each hydrogen or form together a further bond between the two carbon atoms on which they are located. Also described are pharmaceutical compositions comprising the compound of formula I. The compounds of formula I are useful for the treatment of depression, anxiety, bipolar disorder and ADHD.
Patent NZ-501874-A (NZ)
Title: Isolation and characterisation of receptors that are bound by members of the BT-toxin family of insecticidal proteins with respect to pesticides and pest resistance
Inventor: BULLA LEE A
IPC: C07K14/435
Filed: 1998-06-08
Abstract: The cDNA encoding a glycoprotein receptor from the tobacco hornworm (Manduca sexta) that binds a Bacillus thuringiensis (BT) toxin has been obtained and sequenced.  The availability of this cDNA permits the retrieval of DNAs encoding homologous receptors in other insects and organisms as well as the design of assays for the cytotoxicity and binding affinity of potential pesticides and the development of methods to manipulate natural and/or introduced homologous receptors and thus, to destroy target cells, tissues and/or organisms. The isolation and characterisation of a receptor that is bound by members of the BT-toxin family of insecticidal proteins (BT-R1 protein) and a gene encoding the BT-toxin receptor are described.  Compositions and methods for use in identifying agents that bind to the BT-R1 protein as a means for identifying insecticidal agents and for identifying other members of the BT-R1 family are also described.
Patent NZ-510740-A (NZ)
Title: Method for determining warp potential in wood in a nondestructive manner
Inventor: CRAMER STEVEN M
IPC: G01N29/04
Filed: 1999-09-01
Abstract: Nondestructive method for determining warp potential of a  piece of wood whereby the lengthwise shrinkage rate or  a grain  angle  of  the wood is nondestructively  obtained  at least  one location on the wood, and subsequently  the  warp potential determined based on this measurement.
Patent NZ-511308-A (NZ)
Title: Preparation of cross-linked polysaccharides containing carboxy groups, allowing complete control of the degree of cross-linking
Inventor: BARBUCCI ROLANDO
IPC: C08B15/00
Filed: 1999-11-09
Abstract: Described is a process for the preparation of cross-linked polysaccharides containing carboxy groups, allowing complete control of cross-linking degree as well as high reproducibility in terms of constant characteristics of the final product.  The process comprises a first step: activation of the carboxy groups in anhydrous aprotic solvent and then the reaction with a polyamine.  The obtained cross-linked polysaccharide may be subjected to sulphation of the five hydroxy groups.
Patent NZ-513094-A (NZ)
Title: Antiviral nucleoside analogues
Inventor: NGUYEN-BA NGHE
IPC: A61K31/7068
Filed: 1999-12-22
Abstract: Described are cis-nucleoside compounds of formula (I), including (-) enantiomers, (+) enantiomers and racemic mixtures, for which the substituents are defined herein. The compounds are used in the manufacture of medicaments for the treatment of viral infections.
Patent NZ-513803-A (NZ)
Title: Immunomodulatory steroids, in particular the hemihydrate of 16.alpha.-bromoepiandrosterone
Inventor: AHLEM CLARENCE NATHANIEL
IPC: A61P31/04
Filed: 2000-03-23
Abstract: A compound has the formula 1 wherein: the dotted lines are optional double bonds and the hydrogen atom at the 5-position, if present, is in the a-configuration or the b-configuration; R1, R2, R3 and R10 are independently -H, OH, -ORPR, -SRPR, =S, =CH2, N3, NH2, -N(RPR)2, -O-Si-(R13)3, -CN, -NO2, =NOH, =NOC(O)CH3, -C(O)CH3, F, Cl, Br, I, an ester, a thioester, a phosphoester, a phosphothioester, a phosphonoester, a phosphiniester, a sulphite ester, a sulphate ester, an amide, an amino acid, a peptide, an ether, a thioether, an acyl, a thioacyl, a carbonate, a carbamate, a thioacetal, a halogen or an optionally substituted alkyl, alkenyl, alkynyl, aryl moiety, heteroaryl moiety, monosaccharide or oligosaccharide or a nucleoside, a nucleotide, an oligonucleotides or a polymer, each R4, R5, R6 are independently -H, OH, -ORPR, -SRPR, =S, =CH2, N3, NH2, -N(RPR)2, -O-Si-(R13)3, -CN, -NO2, -C(O)CH3, F, Cl, Br, I, an ester, a thioester, a phosphoester, a phosphothioester, a phosphonoester, a phosphiniester, a sulphite ester, a sulphate ester, an amide, an amino acid, a peptide, an ether, a thioether, an acyl, a thioacyl, a carbonate, a carbamate, a thioacetal, a halogen or an optionally substituted alkyl, alkenyl, alkynyl, aryl moiety, heteroaryl moiety, monosaccharide or oligosaccharide or a nucleoside, a nucleotide, an oligonucleotides or a polymer or both R4 can be =O, =S, =CH2, =CH2(CH2)0-15CH3, =NOH or =NOC(O)CH3 or R3 and R4 together comprise a structure of formula 2; R7 is -CHR10-, -CHR10-CHR10-, -CHR10-CHR10-CHR10-, -CHR10-O-CHR10-, -CHR10-S-CHR10-, -CHR10-NRPR-CHR10-, -O-, -O-CHR10-, -S-, -S-CHR10-, -NRPR- or -NRPR-CHR10-; R8 and R9 independently are -CHR10-, -CHR10-CHR10-, -O-, -O-CHR10-, -S-, -S-CHR10-, -NRPR- or -NRPR-CHR10-, or R8 or R9 independently is absent, leaving a 5 membered ring; each R13 independently is alkyl; D is an optionally substituted heterocycle or 4-, 5-, 6-or 7-membered ring that comprises saturated carbon atoms or D comprises two 5-or 6-membered rings, wherein the rings are fused or are linked by 1 or 2 bonds; provided that two or more of R7, R8 and R9 are -O-, -S-,-O-CHR10-, -S-CHR10- or -NRPR-CHR10- and RPR is a protecting group or H. The compounds are useful for treating an immunosuppression condition or an unwanted immune response either or both of which are associated with (1) a pathogen infection, (2) an autoimmune disease, (3) a malignancy or a precancer or (4) a chemotherapy, a radiation therapy, an immunosuppressive therapy, an anti-infective agent therapy, a wound, a burn, the presence of an immunosuppressivemolecule, or gastrointestinal irritation or inflammation.
Patent NZ-523159-A (NZ)
Title: Substrate with a reduced light-scattering, ultraphobic surface and a method for the production of the same
Inventor: REIHS KARSTEN
IPC: C23C26/00
Filed: 2001-05-23
Abstract: A substrate with reduced light-scattering ultraphobic surface that has a total scatter loss of d" 7%, preferably d" 3%, particularly d" 1% and a contact angle in relation to water of at least 140°, preferably at least 150° and the process for its production is disclosed. These substrates are suitable for use as a transparent screen or a covering layer for transparent screens,
Patent NZ-525639-A (NZ)
Title: Means for carrying bottles
Inventor: MIKHAIL N
IPC: A47G23/02
Filed: 2001-04-27
Abstract: The present invention relates to a means for carrying a bottle  (100).  According to a first aspect of  the  present invention  there is provided a carrying means  (100)  for  a bottle  having  a body portion (110), a neck portion  and  a tapered portion extending therebetween, said carrying  means including;  a first bottle retention loop (115)  adapted  to receive  the  body of said bottle therein;  a  carry  handle (125)  connected to said first bottle retention loop  (115); a  second  bottle retention loop (130), adapted  to  receive the  neck of said bottle, therein, and a body portion  (110) connecting  said  first and second loops together,  wherein, in  use  the  body of said bottle is retained in said  first loop  (115), and the neck of said bottle is retained in said second  loop  (130), such that when said carrying  means  is suspended  by  said  carry  handle  (125)  said  bottle   is substantially  supported by said second loop  (130)  against the tapered portion of the bottle.
Patent NZ-533994-A (NZ)
Title: Amino alcohol derivative or phosphonic acid derivative and medicinal compostion containing these
Inventor: NISHI TAKAHIDE
IPC: A61P9/10
Filed: 2003-01-09
Abstract: An amino alcohol derivative or phosphonic acid derivative of general formula (I) each having immunosuppressive activity.
Patent NZ-534953-A (NZ)
Title: Intravascular flow restrictor
Inventor: AMPLATZ KURT
IPC: A61F2/90
Filed: 2002-12-05
Abstract: An intravascular flow restrictor (10) comprises a braided tubular structure designed to be place in the main pulmonary artery for limiting blood pressure in the lungs. The braided structure is designed to be collapsed for placement in a delivery catheter (32) but when ejected from the delivery catheter, assumes a substantially larger diameter disk shaped device having one or more longitudinal channels or passways therethrough.
Patent NZ-540383-A (NZ)
Title: Methods and compositions using selective cytokine inhibitory drugs for treatment and management of chronic uveitis
Inventor: ZELDIS JEROME B
IPC: A61K31/425
Filed: 2003-11-06
Abstract: Use of a selective cytokine inhibitory drug selected from cyclopropyl-N-{2[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-3-oxoisoindoline-4-yl}carboxamide, which has the structure (I) as shown herein: and pharmaceutically acceptable salts and solvates thereof; in the preparation of a composition for treating chronic uveitis is disclosed.
Patent NZ-540936-A (NZ)
Title: Inhalation device for transpulmonary administration
Inventor: YAMASHITA CHIKAMASA
IPC: A61M15/00
Filed: 2003-12-12
Abstract: An inhalation device for transpulmonary administration comprises: a chamber (16) for containing a pharmaceutical composition which is pulverized into fine particles by an air-generated impact for dispersal in air; an air inlet flow path (2) for introducing to the chamber (16) outside air to apply the air-generated impact to the pharmaceutical composition and for injecting the outside air toward the pharmaceutical composition; an inhalation flow path (1) for inhaling the pulverized pharmaceutical composition; a housing (9) for accommodating the chamber (16), the air inlet flow path (2), and the inhalation flow path (1); a mouthpiece (10) provided at one end of the housing (9), the mouthpiece (9) being provided with a mouth-side flow path (21) which communicates with the inhalation flow path (1), and an auxiliary flow path (12).
Patent NZ-541931-A (NZ)
Title: Therapeutic agent for hemorrhoidal disease
Inventor: INAMOTO YUKIKO
IPC: A61K9/00
Filed: 2004-02-17
Abstract: Disclosed is the use of acetylsalicyclic acid or its pharmaceutically acceptable salt in the manufacture of an external medicament for treating anal diseases and for alleviating the pain or pruritus associated with said disease; with the proviso that the only active ingredient of the medicament is acetylsalicyclic acid.